Back to Journals » Neuropsychiatric Disease and Treatment » Volume 6
![](https://www.dovepress.com/cr_data/cache/journal_image/3/cope/thumb_100_1000_100.jpg)
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4230)
- Volume 20, 2024 (124)
- Volume 19, 2023 (249)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 6, 2010
- Issue 1 (84)
- Supplement 1 (6)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Hyperbaric oxygen ameliorates worsening signs and symptoms of post-traumatic stress disorder
Benjamin Eovaldi, Claude Zanetti
Neuropsychiatric Disease and Treatment 2010, 6:785-789
Published Date: 6 December 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Functional imaging of hippocampal dysfunction among persons with Alzheimer’s disease: a proof-of-concept study
David B Arciniegas, Jason R Tregellas, Donald C Rojas, et al
Neuropsychiatric Disease and Treatment 2010, 6:779-783
Published Date: 23 November 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Neurocognitive impairment after off-pump and on-pump coronary artery bypass graft surgery – an Iranian experience
Mehdi Farhoudi, Kaveh Mehrvar, Abbas Afrasiabi, et al
Neuropsychiatric Disease and Treatment 2010, 6:775-778
Published Date: 19 November 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Walking impairment in patients with multiple sclerosis: exercise training as a treatment option
Robert W Motl, Myla D Goldman, Ralph HB Benedict
Neuropsychiatric Disease and Treatment 2010, 6:767-774
Published Date: 16 November 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients
Ann E Maloney, Linmarie Sikich
Neuropsychiatric Disease and Treatment 2010, 6:749-766
Published Date: 10 November 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
Marty Hinz, Alvin Stein, Thomas Uncini
Neuropsychiatric Disease and Treatment 2010, 6:741-747
Published Date: 9 November 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms
Jason T Lerner, Noriko Salamon, Raman Sankar
Neuropsychiatric Disease and Treatment 2010, 6:731-740
Published Date: 8 November 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Update on treatment of partial onset epilepsy: role of eslicarbazepine
Markus Rauchenzauner, Gerhard Luef
Neuropsychiatric Disease and Treatment 2010, 6:723-730
Published Date: 2 November 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Obsessive-compulsive disorder with bipolar diathesis following isotretinoin therapy remitting upon treatment with olanzapine and fluvoxamine
Michele Fornaro
Neuropsychiatric Disease and Treatment 2010, 6:719-722
Published Date: 29 October 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
Adel Gabriel
Neuropsychiatric Disease and Treatment 2010, 6:711-717
Published Date: 29 October 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Could lysine supplementation prevent Alzheimer’s dementia? A novel hypothesis
Robert N Rubey
Neuropsychiatric Disease and Treatment 2010, 6:707-710
Published Date: 27 October 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities
Miho Takenoshita, Tomoko Sato, Yuichi Kato, et al
Neuropsychiatric Disease and Treatment 2010, 6:699-705
Published Date: 13 October 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Neuroendocrine aspects of pediatric aggression: Can hormone measures be clinically useful?
Drew H Barzman, Avni Patel, Loretta Sonnier, et al
Neuropsychiatric Disease and Treatment 2010, 6:691-697
Published Date: 11 October 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Test of variables of attention (TOVA) as a predictor of early attention complaints, an antecedent to dementia
Eric R Braverman, Amanda Lih-Chuan Chen, Thomas JH Chen, et al
Neuropsychiatric Disease and Treatment 2010, 6:681-690
Published Date: 15 October 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Role of paliperidone extended-release in treatment of schizoaffective disorder
Carla M Canuso, Ibrahim Turkoz, Dong Jing Fu, et al
Neuropsychiatric Disease and Treatment 2010, 6:667-679
Published Date: 28 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
Samuel Frank
Neuropsychiatric Disease and Treatment 2010, 6:657-665
Published Date: 28 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
Mike Briley, Chantal Moret
Neuropsychiatric Disease and Treatment 2010, 6:647-655
Published Date: 23 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Treating Lennox–Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide
Jessica Gresham, Lea S Eiland, Allison M Chung
Neuropsychiatric Disease and Treatment 2010, 6:639-645
Published Date: 22 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension
Amresh Shrivastava, Megan E Johnston, Nilesh Shah, et al
Neuropsychiatric Disease and Treatment 2010, 6:633-638
Published Date: 22 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Insight in bipolar disorder: relationship to episode subtypes and symptom dimensions
Frederick Cassidy
Neuropsychiatric Disease and Treatment 2010, 6:627-631
Published Date: 21 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis
Julie A Murphy, Jacklyn A Harris, Andrew J Crannage
Neuropsychiatric Disease and Treatment 2010, 6:619-625
Published Date: 22 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Assessing suicidal risk with antiepileptic drugs
Marco Mula, Gail S Bell, Josemir W Sander
Neuropsychiatric Disease and Treatment 2010, 6:613-618
Published Date: 14 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Brain amyloid β protein and memory disruption in Alzheimer’s disease
Weiming Xia
Neuropsychiatric Disease and Treatment 2010, 6:605-612
Published Date: 7 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Not all partial dopamine D2 receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse
Athan Spiros, Robert Carr, Hugo Geerts
Neuropsychiatric Disease and Treatment 2010, 6:589-603
Published Date: 6 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Brief assessment of negative dysmorphic signs
Patrizia Fiori, Antonio Monaco, Maria Giannetti Luigi
Neuropsychiatric Disease and Treatment 2010, 6:583-587
Published Date: 6 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
Rosaria Di Lorenzo, Alice Brogli
Neuropsychiatric Disease and Treatment 2010, 6:573-581
Published Date: 1 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Once-monthly paliperidone injection for the treatment of schizophrenia
Delia Bishara
Neuropsychiatric Disease and Treatment 2010, 6:561-572
Published Date: 1 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD)
Evangelia Stergiakouli, Anita Thapar
Neuropsychiatric Disease and Treatment 2010, 6:551-560
Published Date: 24 August 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Management of depression in elderly stroke patients
Johan Lökk, Ahmad Delbari
Neuropsychiatric Disease and Treatment 2010, 6:539-549
Published Date: 26 August 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Polyclonal light chains in cerebrovascular disease
Patrizia Fiori, Maria Giannetti Luigi, Linda Iurato, et al
Neuropsychiatric Disease and Treatment 2010, 6:533-537
Published Date: 24 August 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters
Seth D Norrholm, Tanja Jovanovic
Neuropsychiatric Disease and Treatment 2010, 6:517-532
Published Date: 24 August 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Distinguishing between attention-deficit hyperactivity and fetal alcohol spectrum disorders in children: clinical guidelines
Elizabeth Peadon, Elizabeth J Elliott
Neuropsychiatric Disease and Treatment 2010, 6:509-515
Published Date: 12 August 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression
Laura Gedge, Lauren Lazowski, David Murray, et al
Neuropsychiatric Disease and Treatment 2010, 6:501-508
Published Date: 10 August 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Current and emerging treatment options in the management of Friedreich ataxia
Michelangelo Mancuso, Daniele Orsucci, Anna Choub, et al
Neuropsychiatric Disease and Treatment 2010, 6:491-499
Published Date: 30 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo®)
Paolo Solla, Antonino Cannas, Francesco Marrosu, et al
Neuropsychiatric Disease and Treatment 2010, 6:483-490
Published Date: 4 August 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Depressive and adjustment disorders – some questions about the differential diagnosis: case studies
A Presicci, P Lecce, P Ventura, et al
Neuropsychiatric Disease and Treatment 2010, 6:473-481
Published Date: 28 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Lacosamide for the prevention of partial onset seizures in epileptic adults
Anna Kelemen, Péter Halász
Neuropsychiatric Disease and Treatment 2010, 6:465-471
Published Date: 28 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection
Wissam El-Hage, Simon A Surguladze
Neuropsychiatric Disease and Treatment 2010, 6:455-464
Published Date: 28 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Short cognitive behavioral therapy and cognitive training for adults with ADHD – a randomized controlled pilot study
Maarit Virta, Anita Salakari, Mervi Antila, et al
Neuropsychiatric Disease and Treatment 2010, 6:443-453
Published Date: 16 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Emerging role of sertindole in the management of schizophrenia
Stephanie L Cincotta, Joshua S Rodefer
Neuropsychiatric Disease and Treatment 2010, 6:429-441
Published Date: 8 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Armodafinil in the treatment of sleep/wake disorders
Jonathan RL Schwartz, Thomas Roth, Chris Drake
Neuropsychiatric Disease and Treatment 2010, 6:417-427
Published Date: 16 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Reasons for reoperation after epilepsy surgery: a review based on a complex clinical case with three operations
José F Téllez-Zenteno, Farzad Moien-Afshari, Lizbeth Hernández-Ronquillo, et al
Neuropsychiatric Disease and Treatment 2010, 6:409-415
Published Date: 7 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Overview of essential tremor
Theresa A Zesiewicz, Abinaya Chari, Israt Jahan, et al
Neuropsychiatric Disease and Treatment 2010, 6:401-408
Published Date: 7 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, et al
Neuropsychiatric Disease and Treatment 2010, 6:393-400
Published Date: 24 June 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The dual-gate lumen model of renal monoamine transport
Marty Hinz, Alvin Stein, Thomas Uncini
Neuropsychiatric Disease and Treatment 2010, 6:387-392
Published Date: 5 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Faster return to work after psychiatric consultation for sicklisted employees with common mental disorders compared to care as usual. A randomized clinical trial
Christina M van der Feltz-Cornelis, Rob Hoedeman, Fransina J de Jong, et al
Neuropsychiatric Disease and Treatment 2010, 6:375-385
Published Date: 5 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Disease-modifying therapies in relapsing–remitting multiple sclerosis
Fabricio González-Andrade, José Luis Alcaraz-Alvarez
Neuropsychiatric Disease and Treatment 2010, 6:365-373
Published Date: 6 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Getting the balance right: Established and emerging therapies for major depressive disorders
Bojana Perovic, Marija Jovanovic, Branislava Miljkovic, et al
Neuropsychiatric Disease and Treatment 2010, 6:343-364
Published Date: 5 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Leiter-R versus developmental quotient for estimating cognitive function in preschoolers with pervasive developmental disorders
Claudia Portoghese, Maura Buttiglione, Andrea De Giacomo, et al
Neuropsychiatric Disease and Treatment 2010, 6:337-342
Published Date: 28 June 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The role of glatiramer acetate in the early treatment of multiple sclerosis
David W Brandes
Neuropsychiatric Disease and Treatment 2010, 6:329-336
Published Date: 9 June 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
Michael Pennick
Neuropsychiatric Disease and Treatment 2010, 6:317-327
Published Date: 4 June 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Levetiracetam as an alternative therapy for Tourette syndrome
MA Martínez-Granero, A García-Pérez, F Montañes
Neuropsychiatric Disease and Treatment 2010, 6:309-316
Published Date: 26 May 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Management of refractory complex partial seizures: current state of the art
David M Treiman
Neuropsychiatric Disease and Treatment 2010, 6:297-308
Published Date: 26 May 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Abnormal auditory forward masking pattern in the brainstem response of individuals with Asperger syndrome
Johan Källstrand, Olle Olsson, Sara Fristedt Nehlstedt, et al
Neuropsychiatric Disease and Treatment 2010, 6:289-296
Published Date: 31 May 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study
Takahiko Nagamine
Neuropsychiatric Disease and Treatment 2010, 6:281-288
Published Date: 9 June 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
Diana Domnitei, Vishal Madaan
Neuropsychiatric Disease and Treatment 2010, 6:273-279
Published Date: 17 May 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Structured relaxation in the treatment of akathisia: case series
Lars K Hansen, Thomas L’Allemand, Francine Thiry, et al
Neuropsychiatric Disease and Treatment 2010, 6:269-271
Published Date: 25 May 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Long-acting injectable antipsychotics: focus on olanzapine pamoate
JP Lindenmayer
Neuropsychiatric Disease and Treatment 2010, 6:261-267
Published Date: 27 May 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Trazodone effects on [3H]-paroxetine and α2-adrenoreceptors in platelets of patients with major depression
Donatella Marazziti, Giorgio Consoli, Francesca Golia, et al
Neuropsychiatric Disease and Treatment 2010, 6:255-259
Published Date: 10 May 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Optimal management of Alzheimer’s disease patients: Clinical guidelines and family advice
Julia Haberstroh, Harald Hampel, Johannes Pantel
Neuropsychiatric Disease and Treatment 2010, 6:243-253
Published Date: 10 May 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Current trends in drug treatment of obsessive–compulsive disorder
Eric H Decloedt, Dan J Stein
Neuropsychiatric Disease and Treatment 2010, 6:233-242
Published Date: 10 May 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Recurrent schizophrenia-like psychosis as first manifestation of epilepsy: a diagnostic challenge in neuropsychiatry
Willem MA Verhoeven, Jos IM Egger, W Boudewijn Gunning, et al
Neuropsychiatric Disease and Treatment 2010, 6:227-231
Published Date: 3 May 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Neuro-Behçet’s disease: A report of sixteen patients
Radi Shahien, Abdalla Bowirrat
Neuropsychiatric Disease and Treatment 2010, 6:219-225
Published Date: 4 May 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management
Michele Fornaro, Matteo Martino
Neuropsychiatric Disease and Treatment 2010, 6:209-218
Published Date: 1 June 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Role and rationale for the use of milnacipran in the management of fibromyalgia
Jay D Kranzler, R Michael Gendreau
Neuropsychiatric Disease and Treatment 2010, 6:197-208
Published Date: 30 April 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cobalamin deficiency, hyperhomocysteinemia, and dementia
Steven F Werder
Neuropsychiatric Disease and Treatment 2010, 6:159-195
Published Date: 27 April 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Gabapentin enacarbil – clinical efficacy in restless legs syndrome
Pinky Agarwal, Alida Griffith, Henry R Costantino, et al
Neuropsychiatric Disease and Treatment 2010, 6:151-158
Published Date: 22 April 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients
Barbara Błaszczyk, Stanisław J Czuczwar
Neuropsychiatric Disease and Treatment 2010, 6:145-150
Published Date: 20 April 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Hypothyroidism during neonatal and perinatal period induced by thyroidectomy of the mother causes depressive-like behavior in prepubertal rats
Marisol Pineda-Reynoso, Edgar Cano-Europa, Vanessa Blas-Valdivia, et al
Neuropsychiatric Disease and Treatment 2010, 6:137-143
Published Date: 19 April 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes
Jeff C Huffman, Christopher M Celano, James L Januzzi
Neuropsychiatric Disease and Treatment 2010, 6:123-136
Published Date: 5 May 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Role of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesis
E Ece Boylu, R Erdem Togrol, Mehmet Güney Şenol, et al
Neuropsychiatric Disease and Treatment 2010, 6:119-122
Published Date: 7 April 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical management of behavioral characteristics of Prader–Willi syndrome
Alan Y Ho, Anastasia Dimitropoulos
Neuropsychiatric Disease and Treatment 2010, 6:107-118
Published Date: 13 April 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Emotion recognition from stimuli in different sensory modalities in post-encephalitic patients
Yayoi Hayakawa, Masaru Mimura, Hidetomo Murakami, et al
Neuropsychiatric Disease and Treatment 2010, 6:99-105
Published Date: 29 March 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Daytime sleepiness in elderly Parkinson’s disease patients and treatment with the psychostimulant modafinil: A preliminary study
Johan Lökk
Neuropsychiatric Disease and Treatment 2010, 6:93-97
Published Date: 31 March 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Psychiatric comorbidity and suicide risk in patients with chronic migraine
Maurizio Pompili, Gianluca Serafini, Daniela Di Cosimo, et al
Neuropsychiatric Disease and Treatment 2010, 6:81-91
Published Date: 1 April 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomized, double-blind exploratory study
Jean-Pierre Olié, David Gourion, Agnès Montagne, et al
Neuropsychiatric Disease and Treatment 2010, 6:71-79
Published Date: 23 March 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Adolescent mental health: Challenges with maternal noncompliance
Vicki A Nejtek, Sarah Hardy, Scott Winter
Neuropsychiatric Disease and Treatment 2010, 6:67-69
Published Date: 30 March 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Post-traumatic stress in patients with injury-related chronic pain participating in a multimodal pain rehabilitation program
Britt-Marie Stålnacke, Anna Östman
Neuropsychiatric Disease and Treatment 2010, 6:59-66
Published Date: 9 March 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
Izchak Kohen, Paula E Lester, Sum Lam
Neuropsychiatric Disease and Treatment 2010, 6:47-58
Published Date: 2 March 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism
Jean-Michel Azorin, Charles L Bowden, Ricardo P Garay, et al
Neuropsychiatric Disease and Treatment 2010, 6:37-46
Published Date: 3 March 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Role of extended release quetiapine in the management of bipolar disorders
Rayan K Al Jurdi, Lena A Dixit, Martha Sajatovic
Neuropsychiatric Disease and Treatment 2010, 6:29-35
Published Date: 15 February 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference
Steffen Naegel, Mark Obermann
Neuropsychiatric Disease and Treatment 2010, 6:17-28
Published Date: 22 December 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Impulsivity, gender, and the platelet serotonin transporter in healthy subjects
Donatella Marazziti, Stefano Baroni, Irene Masala, et al
Neuropsychiatric Disease and Treatment 2010, 6:9-15
Published Date: 18 December 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Measuring cortisol and DHEA in fingernails: A pilot study
Fay Warnock, Kevin McElwee, Rubo J Seo, et al
Neuropsychiatric Disease and Treatment 2010, 6:1-7
Published Date: 16 December 2009